WallStSmart
CASI

CASI Pharmaceuticals Inc

NASDAQ: CASI · HEALTHCARE · BIOTECHNOLOGY

$0.21
+0.00% today

Updated 2026-06-05

Market cap
$3.21M
P/E ratio
P/S ratio
0.12x
EPS (TTM)
$-3.02
Dividend yield
52W range
$0 – $3
Volume
7.4M

CASI Pharmaceuticals Inc (CASI) Financial statements

SEC filings — annual and quarterly data.

Profit margin
-137.57%
Operating margin
-138.84%
ROE
-1,095.00%
ROA
-61.80%
Debt/equity

Margin trends — annual

Gross margin Operating margin Profit margin
YearRevenueNet incomeGross marginOp. marginProfit margin
2005$5.92M$-16.31M100.00%292.79%-275.65%
2006$6.89M$-49.89M100.00%749.20%-723.62%
2007$7.40M$-22.41M100.00%320.87%-303.03%
2008$7.48M$-23.86M100.00%299.00%-319.13%
2009$5.28M$-8.22M100.00%127.21%-155.49%
2010$3.69M$-8.10M100.00%-122.78%-219.35%
2011$1.94M$-4.56M100.00%-235.36%-234.87%
2012$669310.00$-14.55M100.00%672.93%-2,173.17%
2013$0.00$-5.74M
2014$23727.00$-26.20M68.53%110,370.00%-110,432.45%
2015$47712.00$-7.21M86.85%14,990.78%-15,104.01%
2016$0.00$-9.45M
2017$0.00$-10.77M
2018$0.00$-27.47M
2019$4.13M$-45.36M4.74%-968.07%-1,098.09%
2020$15.14M$-48.29M37.20%-348.60%-318.92%
2021$30.17M$-36.65M58.38%-137.62%-121.50%
2022$43.11M$-41.01M63.28%-61.45%-95.14%
2023$33.88M$-26.94M59.19%-74.03%-79.51%
2024$28.54M$-39.26M39.06%-138.84%-137.57%

Frequently asked questions

What is CASI Pharmaceuticals Inc's revenue?

CASI Pharmaceuticals Inc's trailing twelve-month revenue is $26.85M. Revenue is the top line the whole model builds on, and at this scale the question shifts from how fast it grows to whether margins hold as it compounds.

How profitable is CASI?

In its most recent fiscal year, CASI ran a gross margin of 39.06%, an operating margin of -138.84%, and a net margin of -137.57%. Margins this high mean most of each extra dollar of revenue drops through to profit, which is the signature of real pricing power.

How much free cash flow does CASI generate?

CASI produced $-29.46M in free cash flow in its most recent fiscal year. Free cash flow is what is left after running and reinvesting in the business, and it is the cash that actually funds buybacks, dividends, and a stronger balance sheet.